Last update 13 Jun 2025

Autologous EPCs(Northern Therapeutics)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms-
Target
eNOS
Action
modulators
Mechanism
eNOS modulators(Nitric-oxide synthase, endothelial modulators)
Therapeutic Areas
Respiratory DiseasesOther Diseases
Active Indication-
Inactive Indication
Familial Primary Pulmonary HypertensionIdiopathic pulmonary arterial hypertension
Originator Organization
Northern Therapeutics, Inc.Northern Therapeutics, Inc.
Active Organization-
Inactive Organization
Northern Therapeutics, Inc.Northern Therapeutics, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Autologous EPCs(Northern Therapeutics)
NCT03001414
/ TerminatedPhase 2/3
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
100 Clinical Results associated with Autologous EPCs(Northern Therapeutics)
Login to view more data
100 Translational Medicine associated with Autologous EPCs(Northern Therapeutics)
Login to view more data
100 Patents (Medical) associated with Autologous EPCs(Northern Therapeutics)
Login to view more data
100 Deals associated with Autologous EPCs(Northern Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Familial Primary Pulmonary HypertensionPhase 3
Canada
Northern Therapeutics, Inc.Northern Therapeutics, Inc.
28 Sep 2017
Idiopathic pulmonary arterial hypertensionPhase 3
Canada
Northern Therapeutics, Inc.Northern Therapeutics, Inc.
28 Sep 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free